Neurology
1 drug is in development for Neurodegenerative Diseases.
- Companies
- 1
- Clinical trials
- 10
Prepared research question
Which programs lead the Neurodegenerative Diseases pipeline—and what evidence could change the picture?
Traceable citations · Unknowns marked
Drug Pipeline by Phase
| Drug | Company |
|---|---|
| nexiguran ziclumeran | Intellia Therapeutics, Inc. (NTLA) |
About this indication
Neurodegenerative Diseases context
Also known as: Degenerative Condition, Neurologic, Degenerative Conditions, Neurologic, Degenerative Diseases, Nervous System, Degenerative Diseases, Neurologic, Degenerative Neurologic Disease, Degenerative Neurologic Diseases, Degenerative Neurologic Disorder, Neurodegenerative Disease, Neurodegenerative Disorder, Neurodegenerative Disorders, Neurologic Degenerative Disease, Neurologic Disorders, Degenerative
Frequently asked questions
How many drugs are in development for Neurodegenerative Diseases?
BioSniper tracks 1 drug in development for Neurodegenerative Diseases across 1 company.
How many clinical trials target Neurodegenerative Diseases?
There are 10 clinical trials targeting Neurodegenerative Diseases tracked by BioSniper.